47. Jeong YH, Lee HH, Kim YJ, Lee HR, Lim KH*. (2026) Deubiquitinating Enzymes as Therapeutic Candidates in Hepatocellular Carcinoma and Other Liver Disease. Int J Mol Sci. 27(12), 5625. 

46. Kim YJ, Lee HH, Jung TY, Jeong YH, Lim KH*, Han JM*.  (2026) The Roles of SQSTM1/p62 in Selective Autophagy and Oncogenic Signaling. Int J Mol Sci. Mar 2;27(5):2342.  

45. Ham HJ, Park SS, Lee YS, Kim TH, Son DJ, Kim JH, Lim KH, Park H, Lee HJ, Yun J, Han SB, Choi MK, Hong JT. (2026) CHI3L1 monoclonal antibody therapy mitigates cognitive impairment by inhibiting neuroinflammation through ERK and NF-κB pathway in Tg2576 mice. Front Mol Neurosci. Jan 7;18:1728279.  

44. Park J, Kim B, Ha M, Park M, Ryu H, Yu H, Park S, Roh YS, Lim KH, Hong JT, Han SB, Park CW, Yong SB, Park H. (2026) CRISPRa Lipid Nanocomplex-Mediated Mt3 Targeting Enhances Astrocytic Endocytosis of Amyloid-β in an Alzheimer's Disease Mouse Model. Adv Sci (Weinh). Jan;13(4):e03725. 

43. Yu JE, Shim JH, Yeo IJ, Son DJ, Yun J, Lim KH, Park H, Roh YS, Han SB, Hong JT.  (2025) CHI3L1 promotes cell division through activation of RhoA in lung cancer cells. Cell Commun Signal. Dec 17;24(1):48. 

42. Kim B, Yuk M, Park M, Ryu H, Park J, Yu H, Park S, Hong JT, Lim KH, Han SB, Song N, Park H. (2025) CRISPR editing of miR-33 restores ApoE lipidation and amyloid-β metabolism in ApoE4 sporadic Alzheimer's disease. Brain. Dec 4;148(12):4400-4415. 

41. Gu SM, Kim TH, Park JH, Lim KH, Jun PM, Lee YS, Kweon GR, Hong JT. (2025) Chitinase-3-Like Protein 1 as a Therapeutic Target for Inflammatory Diseases. Biomol Ther (Seoul). Sep 1;33(5):747-757. 

40. Yuk M, Yang S, Yun D, Oh K, Han JM, Lim KH, Dong Q, Wang Z, Song N. (2025) A genome-wide association study for lifetime estrogen exposure identifies novel loci and polygenic signals in East Asian postmenopausal women. Maturitas. Aug;199:108645.  

39. Kim JH, Yang S, Kim H, Vo DK, Maeng HJ, Jo A, Shin JH, Shin JH, Baek HM, Lee GH, Kim SH, Lim KH, Dawson VL, Dawson TM, Joo JY, Lee Y. (2025) Preclinical studies and transcriptome analysis in a model of Parkinson's disease with dopaminergic ZNF746 expression. Mol Neurodegener. Feb 28;20(1):24.

38. Park M, Ryu H, Heo S, Kim B, Park J, Lim KH, Han SB, Park H. (2025) Targeted demethylation of cathepsin D via epigenome editing rescues pathology in Alzheimer's disease mouse model.  Theranostics. Jan 1;15(2):428-438 

37. Lee HK, Kim HK, Kim JY, Kim JS, Park J, Kim MS, Lee TY, Lim KH, Park H, Son DJ, Hong JT, Han SB. (2024) Ingenol-3-Angelate Enhances the B Cell Inhibitory Potential of Mesenchymal Stem Cells, Leading to Marked Alleviation of Lupus Symptoms in MRL. faslpr Mice. Int J Mol Sci. Nov 25(23):12625. 

36. Lee NY, Kyun ML, Yu JE, Kim SO, Lim KH, Lee KH (2024) Transport of Golgi-localized β-catenin p-S47 by KIF11 or KIFC3 induces primary ciliogenesis. Mol Cells Dec;47(12):100142.

35. Lee HH, Han SB, Lim KH* (2024) Neuromyelitis Optica Spectrum Disorder: up-to-date advance researches for a novel therapeutic target. Drug Targets and Therapeutics 

34. Lee JH, Choi HJ, Jeong YJ, Na YH, Hong JT, Han JM*, Hoe HS*, Lim KH* (2024) Developing theragnostics for Alzheimer's disease: Insights from cancer treatment. Int J Biol Macromol. 269(Pt 2):131925

33. Kim B, Yu JE, Yeo IJ, Son DJ, Lee HP, Roh YS, Lim KH, Yun J, Park H, Han SB, Hong JT (2023) (E)-2-methoxy-4-(3-(4-methoxyphenyl)prop-1-en-1-yl)phenol alleviates inflammatory responses in LPS-induced mice liver sepsis through inhibition of STAT3 phosphorylation. Int Immunopharmacol. 125(Pt A):111124

32. Kim SH*, Lim KH*, Yang S*, and Joo JY (2022) Boosting of tau protein aggregation by CD40 and CD48 gene expression in Alzheimer’s disease. FASEB J 37(1):e22702

31. Lim KH* , Yang S* , Kim SH* , Ko E, Kang M, and Joo JY (2022) Cryptic mutation in PLCs of brain disorders: up-to-date discoveries and deep-learning-based approach. Brain  146(4):1267-1280

30. Lim KH*, Kim SH* , Yang S*, Chun S, Joo JY (2021) Advances in multiplex PCR for Alzheimer's disease diagnostics targeting CDK genes. Neurosci Lett 749:135715

29. Lim KH, Yang S, Kim SH, and Joo JY (2021) Identifying new COVID-19 receptor Neuropilin-1 in severe Alzheimer’s diseases patients group brain using genome-wide association study approach. Front Genet 12:741175 

28. Kim SH*, Lim KH*, Yang S, and Joo JY (2021) Long non-coding RNAs in brain tumors: Roles and potential as therapeutic targets. J Hematol Oncol 12:14(17) 

27. Kim SH*, Yang S*, Lim KH*, Ko E, Jang HJ, Kang M, Suh PG, Joo JY (2021) Prediction of Alzheimer’s disease-specific phospholipase c gamma-1 SNV by deep learning-based approach for high-throughput screening. Proc Natl Acad Sci U S A 118:e2011250118 

26. Lim KH, Yang S, Kim SH, Chun S, Joo JY (2020) Discoveries for Long Non-Coding RNA Dynamics in Traumatic Brain Injury. Biology 9:458 

25. Yang S*, Lim KH*, Kim SH, Joo JY (2020) Molecular landscape of long noncoding RNAs in brain disorders. Mol Psychiatry 26(4):1060-1074 

24. Lim KH, Yang S, Kim SH, Joo JY (2020) Elevation of Ace2 as a SARS-CoV-2 entry receptor gene expression in Alzheimer’s disease. J Infect 30:S0163-4453(20)30453-9 

23. Lim KH, Joo JY, Baek KH (2020) The potential roles of deubiquitinating enzymes in brain diseases. Ageing Res Rev 82:100833

22. Lim KH and Joo JY (2020) Predictive Potential of Circulating Ube2h mRNA as an E2 Ubiquitin-Conjugating Enzyme for Diagnosis or Treatment of Alzheimer’s Disease. Int J Mol Sci 21(9), 3398 

21. Cho JG, Choi JS, Lee JH, Cho MG, Kim HS, Noh HD, Lim KH, Park B, Kim JO, Park SG (2019) MED28 Over-Expression Shortens the Cell Cycle and Induces Genomic Instability. Int J Mol Sci 9;20(7) pii: E1746 

20. Cho JG, Lim KH*, Park SG* (2018) MED28 increases the colony-forming ability of breast cancer cells by stabilizing the ZNF224 protein upon DNA damage. Oncol Lett 15:3147-3154 

19. Lim KH, Suresh B, Park JH, Kim YS, Ramakrishna S, Baek KH (2016) Ubiquitin-specific protease 11 functions as a tumor suppressor by modulating Mgl-1 protein to regulate cancer cell growth. Oncotarget 7:14441-14457 

18. Hong SH, Yoon KJ, Lim KH, Um YJ, Cho JG, Jo YJ, Park SG (2016) Tauroursodeoxycholic acid improves viability of artificial RBCs. Biochem Biophys Res Commun 478:1682-7 

17. Lim KH, Song MH, Baek KH (2016) Decision for cell fate: deubiquitinating enzymes in cell cycle checkpoint. Cell Mol Life Sci 73:1439-1455 

16. Cho JG, Park S, Lim CH, Kim HS, Song SY, Roh TY, Sung JH, Suh W, Ham SJ, Lim KH, Park SG (2016) ZNF224, Krüppel like zinc finger protein, induces cell growth and apoptosis-resistance by down-regulation of p21 and p53 via miR-663a. Oncotarget 7:31177-90 

15. Lim KH, Park SG (2015) Transcriptional regulation of KRAB-ZFPs in cancer. Mol Cell Toxicol 11:389-394 

14. Park JJ*, Lim KH*, Baek KH (2015) Annexin-1 regulated by HAUSP is essential for UV-induced damage response. Cell Death Dis 6:e1654 

13. Lim KH, Park JJ, Gu BH, Park SG, Baek KH (2015) HAUSP-nucleolin interaction is regulated by p53-Mdm2 complex in response to DNA damage response. Sci Rep 5:12793 

12. Ahn HJ, Kim KS, Shin KW, Lim KH, Kim JO, Lee JY, Kim J, Park JH, Yang KM, Baek KH, Ko JJ, Park KS (2015) Ell3 stabilizes p53 following CDDP treatment via its effects on ubiquitin-dependent and -independent proteasomal degradation pathways in breast cancer cells. Oncotarget 6:44523-37 

11. Kim JO, Kim SR, Lim KH, Kim JH, Ajjappala B, Lee HJ, Choi JI, Baek KH (2015) Deubiquitinating enzyme USP37 regulating oncogenic function of 14-3-3γ. Oncotarget 6:36551-76 

10. Kim SR, Kim JO, Lim KH, Yun JH, Han I, Baek KH (2015) Regulation of pyruvate kinase isozyme M2 is mediated by the ubiquitin-specific protease 20. Int J Oncol 465:2116-2124. 

9. Lim KH, Kim SR, Ramakrishna S, Baek KH. (2014) Critical lysine residues of Klf4 required for protein stabilization and degradation. Biochem Biophys Res Commun 443(4):1206-10 

8. Lee KW, Cho JG, Kim CM, Kang AY, Kim M, Ahn BY, Chung SS, Lim KH, Baek KH, Sung JH, Park KS, Park SG. (2013) Herpesvirus-associated ubiquitin-specific protease (HAUSP) modulates peroxisome proliferator-activated receptor γ (PPARγ) stability through its deubiquitinating activity. J Biol Chem 288(46):32886-96 

7. Lee CG, Park GY, Han YK, Lee JH, Chun SH, Park HY, Lim KH, Kim EG, Choi YJ, Yang K, Lee CW. (2013) Roles of 14-3-3η in mitotic progression and its potential use as a therapeutic target for cancers. Oncogene 32(12):1560-9 

6. Lim KH, Ramakrishna S, Baek KH. (2013) Molecular mechanisms and functions of cytokine-inducible deubiquitinating enzymes. Cytokine Growth Factor Rev 24(5):427-31 

5. Lim KH, Baek KH. (2013) Deubiquitinating enzymes as therapeutic targets in cancer. Curr Pharm Des 19(22):4039-52 

4. Choi JH, Lim KH, Park E, Kim JY, Choi YK, Baek KH. (2013) Glutamate-ammonia ligase and reduction of G0 population in PANC-1 cells. J Cell Biochem 114(2):303-13 

3. Ramakrishna S, Suresh B, Bae SM, Ahn WS, Lim KH, Baek KH. (2012) Hyaluronan binding motifs of USP17 and SDS3 exhibit anti-tumor activity. PLoS One 2012;7(5):e37772 

2. Ramakrishna S, Suresh B, Lim KH, Cha BH, Lee SH, Kim KS, Baek KH. (2011) PEST motif sequence regulating human NANOG for proteasomal degradation. Stem Cells Dev 

1. Kim MS, Ramakrishna S, Lim KH, Kim JH, Baek KH. (2011) Protein stability of mitochondrial superoxide dismutase SOD2 is regulated by USP36. J Cell Biochem 112(2):498-508